| Sleep duration and risk of all-cause mortality: a flexible, non-linear, meta-regression of 40 prospective cohort studies TZ Liu, C Xu, M Rota, H Cai, C Zhang, MJ Shi, RX Yuan, H Weng, ... Sleep medicine reviews 32, 28-36, 2017 | 312 | 2017 |
| An FGFR 3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers M Mahe, F Dufour, H Neyret‐Kahn, A Moreno‐Vega, C Beraud, M Shi, ... EMBO molecular medicine 10 (4), e8163, 2018 | 62 | 2018 |
| ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer J Yang, C Yang, S Zhang, Z Mei, M Shi, S Sun, L Shi, Z Wang, Y Wang, ... Cancer biology & therapy 16 (8), 1194-1204, 2015 | 53 | 2015 |
| Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer MJ Shi, XY Meng, J Fontugne, CL Chen, F Radvanyi, I Bernard-Pierrot Genome medicine 12, 1-20, 2020 | 52 | 2020 |
| APOBEC-mediated mutagenesis as a likely cause of FGFR3 S249C mutation over-representation in bladder cancer MJ Shi, XY Meng, P Lamy, AR Banday, J Yang, A Moreno-Vega, CL Chen, ... European urology 76 (1), 9-13, 2019 | 52 | 2019 |
| Systematic review and meta-analysis on phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or combined for treatment of LUTS due to BPH XH Wang, X Wang, MJ Shi, S Li, T Liu, XH Zhang Asian journal of andrology 17 (6), 1022-1032, 2015 | 43 | 2015 |
| The role of COL5A2 in patients with muscle-invasive bladder cancer: a bioinformatics analysis of public datasets involving 787 subjects and 29 cell lines XY Meng, MJ Shi, ZH Zeng, C Chen, TZ Liu, QJ Wu, S Li, S Li Frontiers in Oncology 8, 659, 2019 | 39 | 2019 |
| High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer MJ Shi, XY Meng, QJ Wu, XH Zhou Cancer management and research, 2987-2995, 2019 | 36 | 2019 |
| Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis XY Meng, Y Liao, XP Liu, S Li, MJ Shi, XT Zeng OncoTargets and therapy, 1875-1888, 2016 | 32 | 2016 |
| Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells T Liu, Z Fang, G Wang, M Shi, X Wang, K Jiang, Z Yang, R Cao, H Tao, ... Oncology letters 11 (1), 182-188, 2016 | 30 | 2016 |
| Intrafascial versus interfascial nerve sparing in radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis H Weng, XT Zeng, S Li, XY Meng, MJ Shi, DL He, XH Wang Scientific reports 7 (1), 11454, 2017 | 28 | 2017 |
| Circulating tumor cells in breast cancer and its association with tumor clinicopathological characteristics: a meta-analysis BX Yi Liao, Shu-Yi Wang, Xiang-Yu Meng, Jie Yang, Ming-Jun Shi, Hua-Long Liu ... Medical Oncology 31 (12), 1-8, 2014 | 17 | 2014 |
| FGFR3 mutational activation can induce luminal-like papillary bladder tumor formation and favors a male sex bias MJ Shi, J Fontugne, A Moreno-Vega, XY Meng, C Groeneveld, F Dufour, ... European Urology 83 (1), 70-81, 2023 | 12 | 2023 |
| Differential expression profiles and bioinformatics analysis of tRNA-derived small RNAs in muscle-invasive bladder cancer in a Chinese population C Qin, ZH Chen, R Cao, MJ Shi, Y Tian Genes 13 (4), 601, 2022 | 11 | 2022 |
| Association between the TACC3 rs798766 polymorphism and risk of urinary bladder cancer: a synthesis based on current evidence XY Meng, MJ Shi, JF Chen, Y Liao, BW Hu, A Hireche Disease markers 2017 (1), 7850708, 2017 | 11 | 2017 |
| A novel tiRNA-Gly-GCC-1 promotes progression of urothelial bladder carcinoma and directly targets TLR4 C Qin, ZH Chen, R Cao, MJ Shi, Y Tian Cancers 14 (19), 4555, 2022 | 10 | 2022 |
| Integrated Analysis of the fecal metagenome and metabolome in bladder Cancer in a Chinese Population C Qin, Z Chen, R Cao, M Shi, Y Tian Genes 13 (11), 1967, 2022 | 9 | 2022 |
| Proteogenomic characterization of bladder cancer reveals sensitivity to apoptosis induced by tumor necrosis factor–related apoptosis-inducing ligand in FGFR3-mutated tumors CS Groeneveld, V Sanchez-Quiles, F Dufour, M Shi, F Dingli, R Nicolle, ... European urology 85 (5), 483-494, 2024 | 8 | 2024 |
| Alteration of pro-carcinogenic gut microbiota is associated with clear cell renal cell carcinoma tumorigenesis BY Yang, FZ Zhao, XH Li, MS Zhao, JC Lv, MJ Shi, J Li, ZY Zhou, JJ Wang, ... Frontiers in Microbiology 14, 1133782, 2023 | 7 | 2023 |
| Porous Se@SiO2 Nanoparticles Enhance Wound Healing by ROS-PI3K/Akt Pathway in Dermal Fibroblasts and Reduce Scar Formation BY Yang, ZY Zhou, SY Liu, MJ Shi, XJ Liu, TM Cheng, GY Deng, Y Tian, ... Frontiers in Bioengineering and Biotechnology 10, 852482, 2022 | 7 | 2022 |
Isabelle Bernard-Pierrotinstitut curie在 curie.fr 的电子邮件经过验证
